GPT and myeloid sarcoma: In female participants, the risk of MS increased in the ALT level ranges of 10–20 and 20–40 U/L compared with that in ALT <10 U/L, respectively, in the unadjusted model (OR, 3.89 [95% CI, 3.38–4.47]; OR, 10.37 [95% CI, 9.00–11.97]).